Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes

Document Type

Abstract

Publication Date

5-7-2023

Keywords

oregon; cards; cards abstracts

Abstract

Presented at ISPOR—The Professional Society for Health Economics and Outcomes Research Annual Meeting, May 7-10, 2023, Boston, MA

Clinical Institute

Cardiovascular (Heart)

Department

Cardiology

Comments

Rpdriguez PJ, Gratzl S, Lee R, Gilson S, Smits P, Stucky N, Gluckman TJ

This document is currently not available here.


Share

COinS